Dimensional Fund Advisors LP Sio Gene Therapies Inc. Transaction History

Dimensional Fund Advisors LP

7 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Aug 12, 2022	SELL	$0.25 - $0.73 $42,480 - $124,042	-169,921 Reduced 89.12%	20,749 $7,000
Q1 2022 May 13, 2022	SELL	$0.55 - $1.47 $199,135 - $532,234	-362,064 Reduced 65.5%	190,670 $128,000
Q4 2021 Feb 09, 2022	BUY	$1.29 - $2.36 $207,821 - $380,200	161,102 Added 41.14%	552,734 $713,000
Q3 2021 Nov 12, 2021	BUY	$1.81 - $2.7 $530,959 - $792,039	293,348 Added 298.47%	391,632 $850,000
Q2 2021 Aug 12, 2021	BUY	$2.07 - $2.89 $27,715 - $38,694	13,389 Added 15.77%	98,284 $268,000
Q1 2021 May 14, 2021	BUY	$2.34 - $3.44 $119,964 - $176,358	51,267 Added 152.45%	84,895 $222,000
Q4 2020 Feb 25, 2021	BUY	$1.91 - $5.63 $64,229 - $189,325	33,628 New	33,628 $93,000

147K

Ticker SIOX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 73,975,200
Description
Sio Gene Therapies Inc., a clinical-stage company, focuses on developing gene therapies to radically transform the lives of patients with neurodegenerative diseases. It has a license agreement with Oxford BioMedica (UK) Ltd. to develop and commercialize AXO-Lenti-PD and related gene therapy products; and The University of Massachusetts Medical S...

Get notified when there are updates to the investment portfolio of Dimensional Fund Advisors LP, based on Form 13F filings with the SEC.

Stay updated on Dimensional Fund Advisors LP with notifications on news.